A. Y. Leung, C. K. Suen, A. K. Lie, R. H. Liang, K. Y. Yuen et al., Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation, Blood, vol.98, issue.6, pp.1971-1979, 2001.

G. Giraud, P. Priftakis, G. Bogdanovic, M. Remberger, M. Dubrulle et al., BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoitic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts, Bone Marrow Transplant, vol.41, issue.8, pp.737-779, 2008.

P. Silva-lde, P. A. Patah, R. M. Saliba, N. A. Szewczyk, L. Gilman et al.,

M. Lima, Hemorrhagic cystitis after allogeneic hemaopoietic stem cell transplants is the complex result ok BK virus infection, preparative regimen intensity and donor type, Haematologica, vol.95, issue.7, pp.1183-90, 2010.

A. Bedi, C. B. Miller, J. L. Hanson, S. Goodman, R. F. Ambinder et al., Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation, J Clin Oncol, 1995.

A. Ruggeri, G. Roth-guepin, G. Battipaglia, A. C. Mamez, F. Malard et al., Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients, Transpl Infect Dis, vol.17, issue.6, pp.822-852, 2015.

S. R. Solomon, A. Sizemore, M. Sanacore, X. Zhang, S. Brow et al., Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival : results of a prospective phase 2 trial, Biol Blood Marrow Transplant, vol.18, issue.12, pp.1859-1866, 2012.

A. Ruggeri, G. Roth-guepin, G. Battipaglia, A. C. Mamez, F. Malard et al., Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients, Transpl Infect Dis, vol.17, issue.6, pp.822-852, 2015.

A. Y. Leung, C. K. Suen, A. K. Lie, R. H. Liang, K. Y. Yuen et al., Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation, Blood, vol.98, issue.6, pp.1971-1979, 2001.

S. D. Gardner, A. M. Field, D. V. Coleman, and B. Hume, New human papovirus (B.K.) isolated from urine after renal transplantation, Lancet, vol.1, issue.7712, pp.1253-1260, 1971.

J. Corneille and D. Boutolleau, Infections à virus BK après allogreffe de cellules souches hématopoïétiques, Virologie, vol.15, issue.2, pp.115-140, 2011.

A. Bedi, C. B. Miller, J. L. Hanson, S. Goodman, R. F. Ambinder et al., Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation, J Clin Oncol, vol.13, issue.5, pp.1103-1112, 1995.

A. Y. Leung, M. T. Chan, K. Y. Yuen, V. C. Cheng, K. H. Chan et al., Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation, Clin Infect Dis, vol.40, issue.4, pp.528-565, 2005.

A. N. Miller, A. Glode, K. R. Hogan, C. Schaub, C. Kramer et al., Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients

, Biol Blood Marrow Transpl, vol.17, issue.8, pp.1176-81, 2011.

G. Gargiulo, L. Orlando, F. Alberani, G. Crabu, D. Maio et al., Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT) : a prospective observational study of incidence and management in HSCT centre within the GITMO network

. Ecancermedicalscience, , vol.8, p.420, 2014.

C. Phipps, H. Y. Ng, P. Appan, Y. Loh, M. Koh et al., BK-virus prophylaxis: still no answer, Bone Marrow Transplant, vol.48, issue.10, pp.1362-1365, 2013.

M. Philippe, F. Ranchon, L. Gilis, V. Schwiertz, N. Vantard et al., Cidofovir in the treatment of BK Virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, vol.22, issue.4, pp.723-730, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01800025

B. Bridges, S. Donegan, and A. Badros, Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation, Am J Hematol, 2006.

K. V. Rao, L. W. Buie, T. Shea, D. A. Gabriel, T. Comeau et al., Intravesicular cidofovir for the management of BK virus-associated cystitis, Biol Blood Marrow Transplant, vol.15, issue.3, pp.391-393, 2009.

J. Savva-bordalo, P. Vaz, C. Sousa, M. Branca, R. Campilho et al., Clinical effectiveness of hyperbaric oxygen therapy for BKvirus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation, Bone Marrow Transplant, vol.47, issue.8, pp.1095-1103, 2012.

L. Garderet, H. Bittencourt, P. Sebe, A. Kaliski, J. P. Claisse et al., Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients, Transplantation, vol.70, issue.12, pp.1807-1818, 2000.

S. Cesaro, T. Dalianis, H. Rinaldo, C. Koskenvuo, M. Pegoraro et al., ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients, J Antimicrob Chemother, vol.73, issue.1, pp.12-21, 2018.

R. Arthur, K. Shah, S. Baust, G. Santos, and R. Saral, Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants, N Eng J Med, vol.315, issue.4, pp.230-234, 1986.

G. Bogdanovic, P. Priftakis, G. Giraud, M. Kuzniar, R. Ferraldeschi et al., Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation, J Clin Microbiol, vol.42, issue.11, pp.5394-5400, 2004.

N. M. Rorije, M. M. Shea, G. Satyanarayana, S. P. Hammond, V. T. Ho et al., BK virus disease after allogeneic stem cell transplantation : a cohort analysis, Biol Blood Marrow Transplant, 2014.

L. E. Lunde, S. Dasaraju, Q. Cao, C. S. Cohn, M. Reding et al.,

, Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival, Bone Marrow Transplant, vol.50, issue.11, pp.1432-1439, 2015.

. Serment-d'hippocrate,

, Au moment d'être admise à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous, ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Admise dans l'intimité des personnes, je tairai les secrets qui me seront confiés. Reçue à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

, que je sois déshonorée et méprisée si j'y manque